ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Leukemia Society Accepting Grant Applications for ‘88

May 22, 1987

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

Funding Opportunities: CAM Research Center Applications Sought.

January 3, 2003

Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds

February 29, 2008

Spectral Mammography “Like Color vs. Black & White TV”

August 31, 2012

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014